WAUI
GMED icon

WELLINGTON-ALTUS USA INC.’s Globus Medical GMED Stock Holding History

WELLINGTON-ALTUS USA INC.’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.7K Hold
484
– – 0.03% 344
2026
Q1 		$38.2K Sell
484
-117
-19% -$10.5K 0.02% 393
2025
Q4 		$52.5K Buy
+601
New +$45.6K 0.04% 284

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

WELLINGTON-ALTUS USA INC.'s GMED Position: Q2 2026 in Review

WELLINGTON-ALTUS USA INC. held its Globus Medical (GMED) position steady in Q2 2026 at 484 shares worth $41.7K. The position accounts for 0.03% of the portfolio, ranked #344.

WELLINGTON-ALTUS USA INC. first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $52.5K in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • WELLINGTON-ALTUS USA INC. held 484 shares of Globus Medical worth $41.7K as of Q2 2026.
  • WELLINGTON-ALTUS USA INC. left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up 0.03% of WELLINGTON-ALTUS USA INC.'s portfolio in Q2 2026, its #344 holding.
  • WELLINGTON-ALTUS USA INC. first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • WELLINGTON-ALTUS USA INC.'s Globus Medical position peaked at $52.5K in Q4 2025.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on WELLINGTON-ALTUS USA INC.'s 13F filing for Q2 2026, filed 17 Sep 2026.